Publikationen 2017
257.
Pejchinovski M, Mischak H.
Clinical Proteomics in Kidney Disease: From Discovery to Clinical Application
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017, 38(3):39-54.
256.
Magalhães P, Pejchinovski M, Markoska K, Banasik M, Klinger M, Švec-Billá D, Rychlík I, Rroji M, Restivo A, Capasso G, Bob F, Schiller A, Ortiz A, Perez-Gomez MV, Cannata P, Sanchez-Niño MD, Naumovic R, Brkovic V, Polenakovic M, Mullen W, Vlahou A, Zürbig P, Pape L, Ferrario F, Denis C, Spasovski G, Mischak H, Schanstra JP.
Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
Sci Rep. 2017, 7(1):16915.
255.
Krochmal M, Kontostathi G, Magalhães P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, Zoidakis J, Zürbig P, Delles C, Schanstra JP, Mischak H, Vlahou A.
Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
Sci Rep. 2017, 7(1):15160.
254.
Pontillo C, Zhang ZY, Schanstra JP, Jacobs L, Zürbig P, Thijs L, Ramírez-Torres A, Heerspink HJL, Lindhardt M, Klein R, Orchard T, Porta M, Bilous RW, Charturvedi N, Rossing P, Vlahou A, Schepers E, Glorieux G, Mullen W, Delles C, Verhamme P, Vanholder R, Staessen JA, Mischak H, Jankowski J.
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
Kidney Int Rep. 2017, 2(6):1066-1075.
253.
Lindhardt M, Persson F, Zürbig P, Stalmach A, Mischak H, de Zeeuw D, Lambers Heerspink H, Klein R, Orchard T, Porta M, Fuller J, Bilous R, Chaturvedi N, Parving HH, Rossing P.
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study
Nephrol Dial Transplant. 2017, 32(11):1866-1873.
252.
Cherney D, Perkins BA, Lytvyn Y, Heerspink H, Rodríguez-Ortiz ME, Mischak H.
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
PLoS One. 2017, 12(10):e0186910.
251.
Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A.
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
Oncotarget. 2017, 8(41):69435-69455.
250.
Zhang ZY, Ravassa S, Pejchinovski M, Yang WY, Zürbig P, López B, Wei FF, Thijs L, Jacobs L, González A, Voigt JU, Verhamme P, Kuznetsova T, Díez J, Mischak H, Staessen JA.
A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population
Kidney Int Rep. 2017, 2(5):811-820.
249.
Krochmal M, Cisek K, Filip S, Markoska K, Orange C, Zoidakis J, Gakiopoulou C, Spasovski G, Mischak H, Delles C, Vlahou A, Jankowski J.
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis
Sci Rep. 2017 Aug 22;7(1):9091.
248.
Voigtländer T, Metzger J, Schönemeier B, Jäger M, Mischak H, Manns MP, Lankisch TO.
A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin
United European Gastroenterol J. 2017, 5(5):668-676. Epub 2017 Jan 11.
247.
Zhang ZY, Ravassa S, Nkuipou-Kenfack E, Yang WY, Kerr SM, Koeck T, Campbell A, Kuznetsova T, Mischak H, Padmanabhan S, Dominiczak AF, Delles C, Staessen JA.
Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure
J Am Heart Assoc. 2017, 6(8):e005432.
246.
Pontillo C, Jacobs L, Staessen JA, Schanstra JP, Rossing P, Heerspink HJ, Siwy J, Mullen W, Vlahou A, Mischak H, Vanholder R, Zürbig P, Jankowski J.
A urinary proteome-based classifier for the early detection of decline in glomerular filtration
Nephrol Dial Transplant 2017, 32(9):1510-1516.
245.
Pontillo C, Mischak H.
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease
Clin Kidney J. 2017, 10(2):192-201. Epub 2017 Mar 29.
244.
Wei R, Gao B, Shih F, Ranger A, Dearth A, Mischak H, Siwy J, Wisniacki N, Petri M, Burkly LC.
Alterations in urinary collagen peptides in lupus nephritis subjects correlate with renal dysfunction and renal histopathology
Nephrol Dial Transplant. 2017, 32(9):1468-1477.
243.
Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S.
Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Int J Chron Obstruct Pulmon Dis. 2017, 12:829-837.
242.
Ortiz A, Husi H, Gonzalez-Lafuente L, Valiño-Rivas L, Fresno M, Sanz AB, Mullen W, Albalat A, Mezzano S, Vlahou T, Mischak H, Sanchez-Niño MD.
Mitogen-Activated Protein Kinase 14 Promotes AKI
J Am Soc Nephrol. 2017, 28(3):823-836. Epub 2016 Sep 12.
241.
Pejchinovski M, Siwy J, Metzger J, Dakna M, Mischak H, Klein J, Jankowski V, Bae KT, Chapman AB, Kistler AD.
Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression
Nephrol Dial Transplant. 2017, 32(3):487-497.
240.
Htun NM, Magliano DJ, Zhang ZY, Lyons J, Petit T, Nkuipou-Kenfack E, Ramirez-Torres A, von Zur Muhlen C, Maahs D, Schanstra JP, Pontillo C, Pejchinovski M, Snell-Bergeon JK, Delles C, Mischak H, Staessen JA, Shaw JE, Koeck T, Peter K.
Prediction of acute coronary syndromes by urinary proteome analysis
PLoS One. 2017, 12(3):e0172036.
239.
Nkuipou-Kenfack E, Schanstra JP, Bajwa S, Pejchinovski M, Vinel C, Dray C, Valet P, Bascands JL, Vlahou A, Koeck T, Borries M, Busch H, Bechtel-Walz W, Huber TB, Rudolph KL, Pich A, Mischak H, Zürbig P.
The use of urinary proteomics in the assessment of suitability of mouse models for ageing
PLoS One. 2017, 12(2):e0166875.
238.
Albalat A, Mullen W, Husi H, Mischak H.
Tissue Proteomics in Vascular Disease
Methods Mol Biol. 2017, 1527:53-60.
237.
Siebert S, Porter D, Paterson C, Hampson R, Gaya D, Latosinska A, Mischak H, Schanstra J, Mullen W, McInnes I.
Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups
Sci Rep. 2017, 16;7:40473.
236.
Nkuipou-Kenfack E, Zürbig P, Mischak H.
The long path towards implementation of clinical proteomics: Exemplified based on CKD273
Proteomics Clin Appl. 2017, 11(5-6). Epub 2017 Jan 17.
235.
Mokou M, Lygirou V, Vlahou A, Mischak H.
Proteomics in cardiovascular disease: recent progress and clinical implication and implementation
Expert Rev Proteomics. 2017, 14(2):117-136. Epub 2017 Jan 5.